Personal Care Products

Flora Growth

Flora Growth released FY2025 Q3 earnings on November 5, 2025 (EST), actual revenue USD 9.748 M (forecast USD 12.52 M), actual EPS USD -9.0495 (forecast USD -2.13)

Flora Growth released FY2025 9 Months Earnings on November 5 (EST), actual revenue USD 36.33 M, actual EPS USD -5.9446

Flora Growth Secures Funding and Announces AI Strategy, Stock Rises

Flora Growth released FY2025 Semi-Annual earnings on August 1, 2025 (EST) with actual revenue of USD 26.58 M and EPS of USD -6.24

Flora Growth released FY2025 Q2 earnings on August 1 (EST), actual revenue USD 0 (forecast USD 11.77M), actual EPS USD 0 (forecast USD -2.34)

Flora Growth Corp. Has Low P/S Ratio Due to Revenue Decline

Flora Holdings Acquires Key Assets of MC Clinic Holdings

Flora Growth released FY2025 Q1 earnings on May 13 (EST), actual revenue USD 11.79 M (forecast USD 14.79 M), actual EPS USD -0.04 (forecast USD -0.16)

Flora Growth Corp Expected to Report EPS of 3 Cents in Q4 2025

Flora Growth Corp. Releases Q4 2024 Financial Report with Net Loss Reduced to $15.9 Million

Flora Growth released FY2024 Annual Earnings on March 24 (EST), actual revenue USD 59.51 M (forecast USD 59.69 M), actual EPS USD -50.7 (forecast USD -1.08)

Flora Growth released FY2024 Q4 earnings on March 24 (EST), actual revenue $13.33M USD (forecast $13.51M USD), actual EPS -$0.4243 USD (forecast -$0.17 USD)

Flora Growth released FY2024 9 Months Earnings on November 13 Pre-Market (EST), actual revenue USD 25.27 M, actual EPS USD -25.9299

Flora Growth released FY2024 Q3 earnings on November 13 Pre-Market (EST), actual revenue USD 7.238 M (forecast USD 16.75 M), actual EPS USD -11.1099 (forecast USD -3.51)

Flora Growth to Release FY2024 Q3 Earnings on November 14, Pre-Market EST; Forecast Revenue 16.75 M USD, EPS -0.09 USD

Flora Growth and Blossom Genetics Reach Strategic Supply Agreement to Supply Medical Cannabis to Germany

Flora Growth released FY2024 Q2 earnings on August 12 Pre-Market (EST), actual revenue USD 0 (forecast USD 20.74 M), actual EPS USD 0 (forecast USD -1.755)

Flora Growth released FY2024 Semi-Annual earnings on August 12 Pre-Market EST, actual revenue USD 20.98 M, actual EPS USD -22.2114

Flora Growth released FY2024 Q1 earnings on May 14 During-Market EST, actual revenue USD 18.03 M (forecast USD 19.04 M), actual EPS USD -14.8199 (forecast USD -0.22)

Flora Growth Acquires TruHC for $6.4 Million, Anticipating Germany's Cannabis Market Potential Over $10 Billion

Netcapital

Agape ATP

Tradr 2X Long QBTS Daily ETF

Akanda

Defiance Daily Target 2X Long RGTI ETF

PicoCELA

Tradr 2X Long RGTI Daily ETF

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

FLGC

TLRY

Tilray Brands, Canopy Growth, and Flora Growth are highlighted as top cannabis stocks to research, according to MarketBeat. These companies are involved in various aspects of the cannabis industry, including cultivation and distribution. They have shown high trading volumes recently, indicating investor interest. Despite their potential for growth, cannabis stocks carry risks due to regulatory and market volatility. Analysts currently rate Tilray as a Hold, suggesting investors consider other stocks recommended by top analysts.

Market Beat

Tilray Brands

Canopy Growth

Top Cannabis Stocks To Research - February 18th

CNGL

Canopy Growth Corp's short interest has increased by 13.11%, with 40.10 million shares sold short, representing 10.61% of available shares. This rise indicates a more bearish sentiment among investors. It would take an average of 3.43 days for traders to cover their short positions. Compared to its peers, Canopy Growth has a higher short interest percentage of 10.61%, against a peer average of 9.96%.

benzinga_article

Canna-Global Acquisition

Is the Market Bullish or Bearish on Canopy Growth Corp?

Canopy Growth Corp has released its Form 10-Q report for the quarter ending December 31, 2025. Key financial metrics include revenue of $90.391 million, a slight increase from $86.244 million in 2024, and a net loss of $(62.627) million, significantly reduced from $(121.896) million in the same period of 2024. The report highlights stable sales performance in the Cannabis segment, while the Storz & Bickel segment focuses on vaporizers. The company aims to optimize operations and expand market presence, considering potential regulatory changes in the U.S.

TradingView

Canopy Growth Corp SEC 10-Q Report

516930

ARKG

Genflow Biosciences PLC has received administrative approval for €4 million in funding from the Wallonia Region to support the development of its gene therapy candidate GF-1002 for treating Metabolic Dysfunction-Associated Steatohepatitis (MASH). The funding is expected to be disbursed by May 2026 and aligns with the company's 2026 development priorities, focusing on capital efficiency and early-stage collaborations. CEO Dr. Eric Leire emphasized the importance of this funding in advancing their pipeline and maintaining a data-driven approach.

StockTitan

VG Health

Minsheng Royal CSI Biotechnology Theme ETF

Invesco Pharmaceuticals ETF

SPDR Pharmac

iShares Global Healthcare

Guotai CSI Bio-medicine ETF

GF CSI All Share Health Care ETF

Ark Genomic Revolution ETF

ChinaAMC SSE STAR Biology and Medicine ETF

VanEck Pharmaceutical ETF

Health Care Select Sector SPDR

E Fund CSI 300 Health Care ETF

iShares US Pharma

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities | GENFF Stock News

ZSTK

Flora Growth Corp. (NASDAQ: FLGC) has announced the withdrawal of its proposed public offering of common shares. This decision does not constitute an offer to sell or solicit any securities in jurisdictions where it would be unlawful. The company, which will be rebranded as ZeroStack, focuses on decentralized AI asset management and operates a global pharmaceutical distribution business through its subsidiary, Phatebo GmbH. The announcement includes forward-looking statements that involve risks and uncertainties, and the company disclaims any obligation to update these statements.

ZeroStack

Flora Growth Corp. Announces Withdrawal of Proposed Public Offering | FLGC Stock News

Flora Growth(FLGC.US)

Top Cannabis Stocks To Research - February 18th

Is the Market Bullish or Bearish on Canopy Growth Corp?

Canopy Growth Corp SEC 10-Q Report

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities | GENFF Stock News

Flora Growth Corp. Announces Withdrawal of Proposed Public Offering | FLGC Stock News